Oncolytic herpes simplex virus tumor targeting and neutralization escape by engineering viral envelope glycoproteins

Oncolytic herpes simplex viruses (oHSVs) have been approved for clinical usage and become more and more popular for tumor virotherapy. However, there are still many issues for the oHSVs used in clinics and clinical trials. The main issues are the limited anti-tumor effects, intratumor injection, and...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiao-Qin Liu (Author), Hong-Yi Xin (Author), Yan-Ning Lyu (Author), Zhao-Wu Ma (Author), Xiao-Chun Peng (Author), Ying Xiang (Author), Ying-Ying Wang (Author), Zi-Jun Wu (Author), Jun-Ting Cheng (Author), Jia-Fu Ji (Author), Ji-Xin Zhong (Author), Bo-Xu Ren (Author), Xian-Wang Wang (Author), Hong-Wu Xin (Author)
Format: Book
Published: Taylor & Francis Group, 2018-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available